Canaccord Genuity Reiterates a 'Buy' on InterMune Inc. (ITMN); French Grades Supports Final Premium; U.S. Clinical Success
Tweet
Share
E-mailGet Alerts ITMN Hot Sheet
Price: $73.89 --0%
Rating Summary:
8 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
8 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on InterMune Inc. (NASDAQ: ITMN) price target of $24.00.
Analyst, Ritu Baral, said, "Reiterate rating and price target on Esbriet (pirfenidone) positive GBA assessment, potential for blockbuster worldwide sales, US clinical success. Esbriet is ITMN’s drug for idiopathic pulmonary fibrosis (IPF), an orphan lung disease. We see major Esbriet EU commercial potential (despite price concerns), encouraging 2012 adoption, and worldwide peak sales of ~$4B."
Other highlighted points include: 1) French grades supportive of final premium ~$40K price, expected early Q4/12; 2) CEPS admin delays likely to have minimal impact on final price, in our view; and 3) Our EU 2012/2013 estimates are unchanged, as updated timelines match our previously modeled expectations.
For an analyst ratings summary and ratings history on InterMune Inc. click here. For more ratings news on InterMune Inc. click here.
Shares of InterMune Inc. closed at $15.28 yesterday.
Analyst, Ritu Baral, said, "Reiterate rating and price target on Esbriet (pirfenidone) positive GBA assessment, potential for blockbuster worldwide sales, US clinical success. Esbriet is ITMN’s drug for idiopathic pulmonary fibrosis (IPF), an orphan lung disease. We see major Esbriet EU commercial potential (despite price concerns), encouraging 2012 adoption, and worldwide peak sales of ~$4B."
Other highlighted points include: 1) French grades supportive of final premium ~$40K price, expected early Q4/12; 2) CEPS admin delays likely to have minimal impact on final price, in our view; and 3) Our EU 2012/2013 estimates are unchanged, as updated timelines match our previously modeled expectations.
For an analyst ratings summary and ratings history on InterMune Inc. click here. For more ratings news on InterMune Inc. click here.
Shares of InterMune Inc. closed at $15.28 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Viking Holdings (VIK) PT Raised to $82 at Mizuho
- DA Davidson Starts Comfort Systems USA (FIX) at Buy
- Ferrovial SA (FER:SM) (FRRVF) Reiterated at Buy by UBS on Winning Bid For Tennessee Project
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
